Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1144
| Despition | Human GIPR full-length protein-synthetic nanodisc |
| SIZE | 10 µg |
| Source | Synthetic |
| Protein Length | Full length protein. |
| Expression System | HEK293 cells |
| Protein Species | Human |
| Molecular Weight | 53 kDa |
| Form | Lyophilized |
| Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1238 | LIMK1 Blocking Peptide (AC1238) | 250 µg | inquiry |
| ACPP-1577 | Human WWOX Protein (AC1577) | 2 µg | inquiry |
| ACPP-1112 | Recombinant Human Eph Receptor A2 Protein (6×His Tag) (AC1112) | 50 µg | inquiry |
| ACPP-1128 | Recombinant Human Vimentin Protein (AC1128) | 25 µl | inquiry |
| ACPP-1242 | MC3 Receptor Blocking Peptide (AC1242) | 250 µg | inquiry |
| ACPP-1633 | Human PTPS Protein (AC1633) | 5 µg | inquiry |
| ACPP-1487 | Human Pleiotrophin Protein (AC1487) | 5 µg | inquiry |
| ACPP-1216 | PARD3 Blocking Peptide (AC1216) | 250 µg | inquiry |
| ACPP-1335 | Nicotinic Acetylcholine Receptor alpha 7 Blocking Peptide (AC1335) | 250 µg | inquiry |
| ACPP-1828 | Human EPHA2 Protein (AC1828) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.